Valium Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Manufacturer
Mechanism of Action
Valium Indications
Indications
Valium Dosage and Administration
Adult
Children
Valium Contraindications
Contraindications
Valium Boxed Warnings
Boxed Warning
Valium Warnings/Precautions
Warnings/Precautions
Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.
Valium Pharmacokinetics
Absorption
Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.
Distribution
Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.
Elimination
Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).
Valium Interactions
Interactions
Valium Adverse Reactions
Adverse Reactions
Valium Clinical Trials
See Literature
Valium Note
Not Applicable
Valium Patient Counseling
See Literature
Valium Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Manufacturer
Mechanism of Action
Valium Indications
Indications
Valium Dosage and Administration
Adult
Children
Valium Contraindications
Contraindications
Valium Boxed Warnings
Boxed Warning
Valium Warnings/Precautions
Warnings/Precautions
Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.
Valium Pharmacokinetics
Absorption
Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.
Distribution
Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.
Elimination
Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).
Valium Interactions
Interactions
Valium Adverse Reactions
Adverse Reactions
Valium Clinical Trials
See Literature
Valium Note
Not Applicable
Valium Patient Counseling
See Literature
Valium Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Manufacturer
Mechanism of Action
Valium Indications
Indications
Valium Dosage and Administration
Adult
Children
Valium Contraindications
Contraindications
Valium Boxed Warnings
Boxed Warning
Valium Warnings/Precautions
Warnings/Precautions
Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.
Valium Pharmacokinetics
Absorption
Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.
Distribution
Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.
Elimination
Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).
Valium Interactions
Interactions
Valium Adverse Reactions
Adverse Reactions
Valium Clinical Trials
See Literature
Valium Note
Not Applicable
Valium Patient Counseling
See Literature
Valium Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Manufacturer
Mechanism of Action
Valium Indications
Indications
Valium Dosage and Administration
Adult
Children
Valium Contraindications
Contraindications
Valium Boxed Warnings
Boxed Warning
Valium Warnings/Precautions
Warnings/Precautions
Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.
Valium Pharmacokinetics
Absorption
Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.
Distribution
Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.
Elimination
Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).
Valium Interactions
Interactions
Valium Adverse Reactions
Adverse Reactions
Valium Clinical Trials
See Literature
Valium Note
Not Applicable
Valium Patient Counseling
See Literature